The DOI matches its Crossref record; 280 of the 286 references it cites were found in a registry or an index.
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“According to the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, there is likely no lower limit on the amount of moderate-to-vigorous physical activity at which benefits for ASCVD risk start to accrue, and effort should be made to promote achievement of the minimum recommended amount of physical activity (44).”
From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation
Research works printed but not linked: 13
- DeFilippis, 2017, Eur Heart J, 38, 598
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
- Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 · DOI · Paper page
- Mortensen, 2016, A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study, J Am Coll Cardiol, 68, 881, 10.1016/j.jacc.2016.05.084 · DOI
- Nasir, 2015, Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 66, 1657, 10.1016/j.jacc.2015.07.066 · DOI
- Yano, 2017, Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies, JAMA Cardiol, 2, 986, 10.1001/jamacardio.2017.2498 · DOI
- Budoff, 2018, Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA), Eur Heart J, 39, 2401, 10.1093/eurheartj/ehy217 · DOI · Paper page
- Whelton, 2018, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 · DOI · Paper page
- Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group, N Engl J Med, 344, 3, 10.1056/NEJM200101043440101 · DOI · Paper page
- Bress, 2017, Cost-effectiveness of intensive versus standard blood-pressure control, N Engl J Med, 377, 745, 10.1056/NEJMsa1616035 · DOI
- Patnode, 2015, Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force, Ann Intern Med, 163, 608, 10.7326/M15-0171 · DOI · Paper page
- Guirguis-Blake, 2016, Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 164, 804, 10.7326/M15-2113 · DOI
Cited by
Sorted by citations
Items 301–400 of 1,000
Off-Target Effects of Antidepressants on Vascular Function and Structure
Dimoula, A., Fotellis, D., Aivalioti, E., Delialis, D., Polissidis, A., Patras, R., Kokras, N., & Stamatelopoulos, K. S. (2021) · Biomedicines · doi:10.3390/biomedicines10010056 · Cited by 22
Neuroticism, Worry, and Cardiometabolic Risk Trajectories: Findings From a 40‐Year Study of Men
Lee, L. O., Grimm, K. J., Spiro, A., & Kubzansky, L. D. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022006 · Cited by 24
Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study
Eadon, M. T., Maddatu, J., Moe, S. M., Sinha, A. D., Ferreira, R. M., Miller, B. W., Sher, S. J., Su, J., Pratt, V. M., Chapman, A. B., et al. (2021) · Kidney360 · doi:10.34067/kid.0005362021 · Cited by 21
Upshaw, J. N., Nelson, J., Rodday, A. M., Kumar, A. J., Klein, A. K., Konstam, M. A., Wong, J. B., Jaffe, I. Z., Ky, B., Friedberg, J. W., et al. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.0303 · Cited by 21
Fink, R. M., Mooney, E. V., Saseen, J. J., & Billups, S. J. (2019) · Pharmacy Practice · doi:10.18549/pharmpract.2019.4.1618 · Cited by 21
Caldeira, D., Alves, M., David, C., Costa, J. N., Ferreira, J. J., & Pinto, F. J. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.11.004 · Cited by 21
Waltz, J. T., Kocher, M., Kahn, J., Dirr, M. A., & Burt, J. R. (2020) · Cureus · doi:10.7759/cureus.8574 · Cited by 21
Challenging 2019 ESC guidelines for the management of type 2 diabetes
Scheen, A. J. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.10.006 · Cited by 20
High-sensitive C-reactive protein in patients with coronary artery disease
Patil, V. C., Avhad, A., Kulkarni, A., & Pandere, K. (2020) · Journal of Natural Science Biology and Medicine · doi:10.4103/jnsbm.jnsbm_159_19 · Cited by 20
The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology Management
Soni, M., Ambrosino, M., & Jacoby, D. S. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01490-7 · Cited by 20
Coronary artery calcium score: Current status of clinical application and how to handle the results
Suzuki, Y., Matsumoto, N., Yoda, S., Amano, Y., & Okumura, Y. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.11.020 · Cited by 20
Kwon, Y., Lee, H., Baik, S. J., Chang, H., & Lee, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.824574 · Cited by 20
Chitturi, K. R., Burns, E. A., Muhsen, I. N., Anand, K., & Trachtenberg, B. H. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01215-1 · Cited by 20
Jucan, A. E., Gavrilescu, O., Dranga, M., Popa, I. V., Mihai, B. M., Prelipcean, C. C., & Mihai, C. (2022) · Life · doi:10.3390/life12081113 · Cited by 20
Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease
Jiang, Z., Jiang, X., Chen, A., & He, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1238647 · Cited by 20
Trivedi, R., Elshafie, S., Tackett, R. L., Young, H. N., & Sattler, E. L. P. (2023) · Journal of Medical Internet Research · doi:10.2196/49178 · Cited by 20
Hodgkin lymphoma treatment for older persons in the modern era
Evens, A. M., McKenna, M., Tiger, Y. K., & Upshaw, J. N. (2023) · Hematology · doi:10.1182/hematology.2023000449 · Cited by 20
The ins and outs of lipoprotein(a) assay methods
Heydari, M., Rezayi, M., Ruscica, M., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A. (2024) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad/176653 · Cited by 21
Shah, R., Khan, B., Latham, S. B., Khan, S., & Rao, S. V. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.05.015 · Cited by 20
Li, Y., Yatsuya, H., Tanaka, S., Iso, H., Okayama, A., Tsuji, I., Sakata, K., Miyamoto, Y., Ueshima, H., Miura, K., et al. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.58958 · Cited by 20
Evolution and Outcomes of Premature Coronary Artery Disease
Smith, C. L., Seigerman, M. E., Adusumalli, S., Giri, J. S., Fiorilli, P. N., Kolansky, D. M., & Kobayashi, T. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01457-8 · Cited by 23
Kim, S. J., Kwon, O. D., & Kim, K. S. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01455-3 · Cited by 22
Sustainable Diets for Cardiovascular Disease Prevention and Management
Mendoza-Vasconez, A. S., Landry, M. J., Crimarco, A., Bladier, C., & Gardner, C. D. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00929-0 · Cited by 20
Jiang, R., Wang, T., Han, K., Peng, P., Zhang, G., Wang, H., Zhao, L., Liang, H., Lv, X., & Du, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1549831 · Cited by 25
Insulin Resistance and Diabetes Mellitus in Patients with Systemic Lupus Erythematosus
García‐Carrasco, M., Pinto, C. M., Munguía‐Realpozo, P., Etchegaray‐Morales, I., Vélez-Pelcastre, S. K., Méndez‐Martínez, S., Zamora‐Ginez, I., de Lara, L. G. V., Gálvez-Romero, J. L., & Escamilla-Márquez, M. A. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220908154253 · Cited by 20
Santis, F. D., Romoli, M., Foschi, M., Sciancalepore, F., D’Anna, L., Barba, L., Abu‐Rumeileh, S., Sacco, S., & Ornello, R. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332457 · Cited by 26
SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class
Schernthaner, G., Drexel, H., Moshkovich, E., Žilaitienė, B., Martinka, E., Czupryniak, L., Várkonyi, T. T., Janež, A., Ducena, K., Lalic, K. S., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0387-y · Cited by 21
The dilemma of aspirin resistance in obese patients
Ardeshna, D. R., Khare, S., Jagadish, P. S., Bhattad, V. B., Cave, B. E., & Khouzam, R. N. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.52 · Cited by 19
Nudy, M. S., Cooper, J., Ghahramani, M., Ruzieh, M., Mandrola, J. M., & Foy, A. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.04.028 · Cited by 19
Obisesan, O. H., Osei, A. D., Berman, D. S., Dardari, Z., Uddin, S. M. I., Dzaye, O. D. A., Orimoloye, O. A., Budoff, M. J., Miedema, M. D., Rumberger, J. A., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.02.038 · Cited by 19
Self-citationMindfulness for Outpatient Oncology Nurses: A Pilot Study
Qualls, B. W., Payton, E. M., Aikens, L. G., & Carey, M. G. (2022) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000487 · Cited by 18
Ji, H., Wang, X., Sia, C., Yap, J. J. L., Lim, S. T., Djohan, A. H., Chang, Y., Zhang, N., Guo, M., Li, F., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00802-0 · Cited by 18
“The American College of Cardiology and American Heart Association provideguidelinesandrecommendationsforCVDpreventionss 6,21,22 .”
Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?
Kikuchi, R., Shah, N. P., & Dent, S. F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040896 · Cited by 18
Gaffey, A. E., Jeon, S., Conley, S., Jacoby, D. L., Ash, G. I., Yaggi, H. K., O’Connell, M., Linsky, S., & Redeker, N. S. (2020) · Behavioral Sleep Medicine · doi:10.1080/15402002.2020.1762601 · Cited by 18
“Cardiovascular prevention guidelines have only recently recommended assessing psychosocial stressors and sleep disturbance (Arnett et al., 2019), among people with cardiovascular disease, including those with HF (Yancy et al., 2017, 2013).”
BackgroundUpshaw, J. N., Hubbard, R. A., Hu, J., Brown, J. C., Smith, A. M., Demissei, B. G., Schmitz, K. H., & Ky, B. (2020) · Cancer Medicine · doi:10.1002/cam4.3277 · Cited by 18
Pan, J., Cao, Z., Fang, C., Lei, Y., Sun, J., Huang, X., & Han, D. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.722530 · Cited by 19
“With the intensification of global aging, cardiovascular diseases have become the main cause of death (Arnett et al., 2019).”
BackgroundKim, Y. (2021) · Journal of Nursing Research · doi:10.1097/jnr.0000000000000465 · Cited by 18
“The 2019 American College of Cardiology/American Heart Association Guidelines on the Prevention of Cardiovascular Disease emphasize the need to make improvements for healthy lifestyles (Arnett et al., 2019).”
BackgroundChronic aspirin use and survival following sepsis—A propensity-matched, observational cohort study
Lavie, I., Lavie, M., Gafter‐Gvili, A., Halperin, E., Abramovich-Yoffe, H., & Avni, T. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.04.010 · Cited by 18
Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event
Qu, H., Long, L., Chen, L., Wu, H.-T., Fu, C., & Zhang, S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.994329 · Cited by 18
Pugliese, L., Ricci, F., Sica, G., Scaglione, M., & Masala, S. A. (2023) · Diagnostics · doi:10.3390/diagnostics13122074 · Cited by 19
Koneru, S. C., Sikand, G., & Agarwala, A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.06.078 · Cited by 20
Series: Implications of the recent CVOTs in type 2 diabetes
Scheen, A. J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.005 · Cited by 18
Raggi, P. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.08.009 · Cited by 18
Sharma, A., Aziz, H., Verma, S., Abramson, B. L., Choi, R., Chua, G. L., Connelly, K. A., Honos, G. N., Mancini, G. B. J., Ramer, S. A., et al. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000892 · Cited by 19
Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris
Koschitzky, M., Navrazhina, K., Garshick, M. S., Gonzalez, J., Han, J. K., Garcet, S., & Krueger, J. G. (2022) · Experimental Dermatology · doi:10.1111/exd.14582 · Cited by 18
Physical activity, CVD, and older adults
Ferraro, R., Pallazola, V. A., & Michos, E. D. (2019) · Aging · doi:10.18632/aging.101942 · Cited by 18
Self-citationKalra, D. K., Ray, K. K., Bajaj, A., Kushner, P. R., Wilcox, M. L., Dicklin, M. R., Kirkpatrick, C. F., & Maki, K. C. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.02.006 · Cited by 18
Bailly, M., Thibault, F., Courtehoux, M., Metrard, G., Angoulvant, D., & Ribeiro, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.691893 · Cited by 17
Stair climbing activity and vascular function in patients with hypertension
Yamaji, T., Harada, T., Hashimoto, Y., Nakano, Y., Kajikawa, M., Yoshimura, K., Chayama, K., Goto, C., Han, Y., Mizobuchi, A., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00697-z · Cited by 18
Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis
Martínez‐Ceballos, M. A., Rey, J. C. S., Álzate, J. P., Pinto, C. M., García‐Carrasco, M., Montes-Zabala, L., Vergara, D. V., Munguía‐Realpozo, P., Etchegaray‐Morales, I., & Rojas‐Villarraga, A. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.017 · Cited by 17
Chen, P., Tsai, S., Pan, C., Chen, Y.-L., Su, S., Chen, C.-C., & Kuo, C. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211046891 · Cited by 18
“Although most well-known vascular risk factors are lifestyle-related (Arnett et al., 2019; Kotseva et al., 2019), our results, along with those of previous studies (Goldstein et al., 2015; Hatch et al., 2015; Naiberg et al., 2017; Westman et al., 2013), suggest that vascular risks are similar in…”
ResultTurini, E., Sarsale, M., Petri, D., Totaro, M., Lucenteforte, E., Tavoschi, L., & Baggiani, A. (2022) · Foods · doi:10.3390/foods11060839 · Cited by 17
Adorni, R., Greco, A., D’Αddario, M., Zanatta, F., Fattirolli, F., Franzelli, C., Maloberti, A., Giannattasio, C., & Steca, P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084700 · Cited by 22
Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease
Egbe, A. C., Miranda, W. R., López-Jiménez, F. A., & Connolly, H. M. (2022) · JACC Advances · doi:10.1016/j.jacadv.2022.100026 · Cited by 17
Adverse Pregnancy Outcomes and Postpartum Care as a Pathway to Future Health
Barry, V. G., JOHNSON, T. N., Herrick, C., Lindley, K. J., & Carter, E. B. (2022) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000724 · Cited by 23
BMI modifies HDL-C effects on coronary artery bypass grafting outcomes
Rezaee, M., Fallahzadeh, A., Sheikhy, A., Jameie, M., Behnoush, A. H., Pashang, M., Tajdini, M., Tavolinejad, H., Masoudkabir, F., Mansourian, S., et al. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01739-2 · Cited by 18
Long-term, in vivo therapeutic effects of a single dose of miR-145 micelles for atherosclerosis
Chin, D. D., Patel, N., Lee, W., Kanaya, S., Cook, J., & Chung, E. J. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.04.001 · Cited by 19
Kim, H., & Kim, M. (2023) · Korean Circulation Journal · doi:10.4070/kcj.2023.0205 · Cited by 18
Germanèse, C., Mériaudeau, F., Eid, P., Tadayoni, R., Dominique Ginhac, B., Anwer, A., Steinberg, L.-A., Guénancia, C., Creuzot-Garcher, C. P., Gabrielle, P., et al. (2023) · Data · doi:10.3390/data8100147 · Cited by 17
Beyond the Basics: Unraveling the Complexity of Coronary Artery Calcification
Hashmi, S., Shah, P. W., Aherrahrou, Z., Aïkawa, E., & Aherrahrou, R. (2023) · Cells · doi:10.3390/cells12242822 · Cited by 17
Understanding activity and physiology at scale: The Apple Heart & Movement Study
Truslow, J. G., Spillane, A., Lin, H., Cyr, K., Ullal, A. V., Arnold, E. M., Huang, R., Rhodes, L., Block, J. M., Stark, J., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01187-5 · Cited by 20
Semenchuk, B. N., Boreskie, K. F., Hay, J. L., Miller, C., Duhamel, T. A., & Strachan, S. M. (2020) · Journal of Health Psychology · doi:10.1177/1359105320909860 · Cited by 17
“The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life (e.g. healthy eating and physical activity (PA); Arnett et al., 2019).”
BackgroundBebu, I., Braffett, B. H., Orchard, T. J., Lorenzi, G. M., Nathan, D. M., Herman, W. H., & Lachin, J. M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108591 · Cited by 17
White‐Williams, C., Shirey, M. R., Eagleson, R. M., Clarkson, S. A., & Bittner, V. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.04.011 · Cited by 18
Adorni, R., Zanatta, F., D’Αddario, M., Atella, F., Costantino, E., Iaderosa, C., Petarle, G., & Steca, P. (2021) · Nutrients · doi:10.3390/nu13113778 · Cited by 18
Mahabamunuge, J., Sekula, N. M., Lepore, C., Kudrimoti, M., Upadhyay, A., Alshowaikh, K., Li, H. J., Seifer, D. B., & AlAshqar, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030709 · Cited by 23
“For individuals with indeterminate or intermediate risk, coronary artery calcification scoring via CT imaging may be performed [134].”
Masson, W. M., Villar, G. M. F., & Elhelou, S. M. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03154-2 · Cited by 16
“The 2019 update of the ACC/AHA guide‑ lines on primary prevention of cardiovascular disease identifies certain chronic inflammatory diseases, such as psoriasis, rheumatoid arthritis, lupus, and HIV, as risk‑enhancing factors [72].”
Sakizlian, D. D. M., Boldeanu, L., Mitrea, A., Clenciu, D., Vladu, I. M., Plasiciuc, A. E. C., Șarla, A. V., Siloşi, I., Boldeanu, M. V., Assani, M.-Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136227 · Cited by 16
Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial
Bonnet, F., Bénard, A., Poulizac, P., Afonso, M., Maillard, A., Salvo, F., Berdaï, D., Salles, N., Rousselot, N., Marchi, S., et al. (2020) · Trials · doi:10.1186/s13063-020-04259-5 · Cited by 17
Cardiovascular Risk Assessment in the Older Athlete
Moorman, A. J., Dean, L. S., Yang, E., & Drezner, J. A. (2021) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381211004877 · Cited by 18
The potential of glucagon-like peptide-1 receptor agonists in heart failure
Kreiner, F. F., Hovingh, G. K., & von Scholten, B. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.983961 · Cited by 17
The Economic Burden of Illness
Weintraub, W. S. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.2663 · Cited by 16
Khawaja, T., Linge, J., Leinhard, O. D., Al-Kindi, S. G., Rajagopalan, S., Khera, A., de Lemos, J. A., Joshi, P. H., & Neeland, I. J. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.03.002 · Cited by 16
Self-citationAssociation of obesity with cardiovascular disease in the absence of traditional risk factors
Luo, H., Liu, Y., Tian, X., Zhao, Y., Liu, L., Zhao, Z., Luo, L., Zhang, Y., Jiang, X., Liu, Y., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01408-z · Cited by 16
Zahid, S., Mohamed, M. S., Rajendran, A., Minhas, A. S., Khan, M. Z., Nazir, N. T., Ocon, A. J., Weber, B., Isiadinso, I., & Michos, E. D. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae108 · Cited by 16
Self-citationGennari, A. G., Rossi, A., De Cecco, C. N., van Assen, M., Sartoretti, T., Giannopoulos, A. A., Schwyzer, M., Huellner, M. W., & Messerli, M. (2024) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-024-03080-4 · Cited by 16
Cuny, T., Reynaud, R., Raverot, G., Coutant, R., Chanson, P., Kariyawasam, D., Poitou, C., Thomas‐Teinturier, C., Baussart, B., Samara‐Boustani, D., et al. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.07.002 · Cited by 19
Saha, S., Nordström, J., Mattisson, I., Nilsson, P. M., & Gerdtham, U. (2019) · Nutrients · doi:10.3390/nu11061434 · Cited by 16
Carbohydrates: Separating fact from fiction
Blaak, E. E., Riccardi, G., & Cho, L. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.03.025 · Cited by 18
Impact of Age and Sex on Subclinical Coronary Atherosclerosis in a Healthy Asian Population
Wong, M. Y. Z., Yap, J. J. L., Huang, W., Tan, S. Y., & Yeo, K. K. (2021) · JACC Asia · doi:10.1016/j.jacasi.2021.05.002 · Cited by 17
Giussani, M., Orlando, A., Tassistro, E., Lieti, G., Patti, I., Antolini, L., Parati, G., & Genovesi, S. (2022) · Nutrients · doi:10.3390/nu14051034 · Cited by 17
Malik, A. O., Peri-Okonny, P., GOSCH, K. L., Thomas, M. B., Mena‐Hurtado, C., Hiatt, W. R., Aronow, H. D., Jones, P. G., Provance, J., Labrosciano, C., et al. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110313 · Cited by 19
“Through an interplay of these complex mechanisms stress is a potent cardiovascular risk factor [7] and the latest American College of Cardiology guidelines on prevention lay emphasis on addressing psychosocial stressors in patients with cardiovascular disease[9].”
BackgroundPsoriasis and Cardiovascular Disease—An Ounce of Prevention Is Worth a Pound of Cure
Garshick, M. S., & Berger, J. S. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.4723 · Cited by 17
Sezer, H., Yazıcı, D., Çöpür, S., Dağel, T., Deyneli, O., & Kanbay, M. (2020) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000491 · Cited by 15
WHO cardiovascular disease risk prediction model performance in 10 regions, China
Yang, S.-C., Ding, Y., Yu, C.-Q., Guo, Y., Pang, Y., Sun, D., Pei, P., Yang, L., Chen, Y.-P., Du, H., et al. (2023) · Bulletin of the World Health Organization · doi:10.2471/blt.22.288645 · Cited by 15
Yilmaz, Y. N. (2023) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2023.2023.0011 · Cited by 15
“[51] 55] This risk calculation should be repeated every five years.”
BackgroundTranscriptome-wide association study reveals novel susceptibility genes for coronary atherosclerosis
Zhao, Q., Liu, R., Chen, H., Yang, X., Dong, J., Bai, M., Lu, Y., & Leng, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1149113 · Cited by 15
Obisesan, O. H., Boakye, E., Wang, F. M., Dardari, Z., Dzaye, O. D. A., Cainzos‐Achirica, M., Meyer, M. L., Gottesman, R. F., Palta, P., Coresh, J., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117475 · Cited by 15
Demographic diversity in platelet function and response to antiplatelet therapy
Jain, K., Tyagi, T., Gu, S. X., Faustino, E. V. S., & Hwa, J. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.11.005 · Cited by 15
Lu, W., Li, Y., Montayre, J., Li, M., Ho, K. Y., Li, J., & Yorke, J. (2025) · Healthcare · doi:10.3390/healthcare13030305 · Cited by 18
Tian, J., Yan, J., Zhang, Q., Yang, H., Chen, X., Han, Q., Han, R., Ren, J. L., Zhang, Y., & Han, Q. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s218694 · Cited by 15
Aminde, L. N., Phung, H. N., Phung, D. T., Cobiac, L. J., & Veerman, L. J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.682975 · Cited by 15
Sweeney, T. E., Ogunmoroti, O., Ndumele, C. E., Zhao, D., Varma, B., Allison, M., Budoff, M. J., Fashanu, O. E., Sharma, A., Bertoni, A. G., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.11.002 · Cited by 15
Self-citationCardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
Eckel, R. H., Farooki, A., Henry, R. R., Koch, G. G., & Leiter, L. A. (2019) · Clinical Diabetes · doi:10.2337/cd19-0001 · Cited by 15
Schwarz, D., Dhungana, S. K., Kumar, A., Acharya, B., Agrawal, P. K. B., Aryal, A., Baum, A., Choudhury, N., Citrin, D., Dangal, B., et al. (2020) · Trials · doi:10.1186/s13063-020-4063-3 · Cited by 15
Access and Delivery of Adult Congenital Heart Disease Care in the United States
Fernandes, S. M., Marelli, A. J., Hile, D. M., & Daniels, C. J. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.04.012 · Cited by 15
Diversity is richness: why data reporting according to sex, age, and ethnicity matters
Lüscher, T. F., Miller, V. M., Merz, C. N. B., & Crea, F. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa277 · Cited by 15
Fernández‐Álvarez, V., Linares-Sánchez, M., López, F., Rinaldo, A., & Ferlito, A. (2025) · Cardiology and Therapy · doi:10.1007/s40119-025-00428-2 · Cited by 14
“The 2021 ESC guidelines and the AHA/ACC guide‑ lines do not recommend CIMT for systematic risk assessment due to a lack of methodologi‑ cal standardization and its limited incremental predictive value [13, 22].”
InfluentialPreventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome
Ahmad, M. I., & Shapiro, M. D. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00913-8 · Cited by 14
Stress testing and noninvasive coronary imaging: What’s the best test for my patient?
Matta, M., Harb, S. C., Cremer, P. C., Hachamovitch, R., & Ayoub, C. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20068 · Cited by 14
Metadata
- Authors
- Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B.
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 74
- Issue
- 10
- Pages
- 1376-1414
- ISSN
- 0735-1097 (ISSN-L)
- PMC
- PMC8344373
- OpenAlex
- W2984766121
- Cited by
- 1,193
- References
- 286
- Citations by year
- 2026: 87 · 2025: 140 · 2024: 131 · 2023: 167 · 2022: 191 · 2021: 207 · 2020: 191 · 2019: 79
- FWCI
- 153.80
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Heart Association (17SDG33630113)
- National Institutes of Health (KL2TR001882)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- primary prevention, cardiovascular disease, cardiovascular risk factors, cardiovascular disease prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review